TPEX:4183

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

EPS Bio Technology

Market Cap

NT$476.0m

Last Updated

2021/06/22 08:36 UTC

Data Sources

Company Financials

Executive Summary

EPS Bio Technology Corp. manufactures and sells OEM/ODM glucose meters and strips primarily in Taiwan. More Details


Snowflake Analysis

Flawless balance sheet with solid track record.

Share Price & News

How has EPS Bio Technology's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 4183 is less volatile than 75% of TW stocks over the past 3 months, typically moving +/- 2% a week.

Volatility Over Time: 4183's weekly volatility (2%) has been stable over the past year.


Market Performance


7 Day Return

-1.0%

4183

5.6%

TW Medical Equipment

-1.3%

TW Market


1 Year Return

-13.0%

4183

-2.2%

TW Medical Equipment

45.3%

TW Market

Return vs Industry: 4183 underperformed the TW Medical Equipment industry which returned -2.2% over the past year.

Return vs Market: 4183 underperformed the TW Market which returned 45.3% over the past year.


Shareholder returns

4183IndustryMarket
7 Day-1.0%5.6%-1.3%
30 Day-0.7%12.5%5.2%
90 Day-10.1%16.0%6.3%
1 Year-10.7%-13.0%-0.03%-2.2%49.9%45.3%
3 Year22.9%13.0%22.4%12.0%74.8%55.6%
5 Year22.9%6.3%11.6%-3.1%138.4%97.3%

Long-Term Price Volatility Vs. Market

How volatile is EPS Bio Technology's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is EPS Bio Technology undervalued compared to its fair value and its price relative to the market?

21.57x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: 4183 (NT$20) is trading above our estimate of fair value (NT$18.09)

Significantly Below Fair Value: 4183 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 4183 is poor value based on its PE Ratio (21.6x) compared to the TW Medical Equipment industry average (20.4x).

PE vs Market: 4183 is poor value based on its PE Ratio (21.6x) compared to the TW market (17.5x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 4183's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 4183 is good value based on its PB Ratio (1.6x) compared to the TW Medical Equipment industry average (2.1x).


Future Growth

How is EPS Bio Technology forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

19.2%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as EPS Bio Technology has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has EPS Bio Technology performed over the past 5 years?

10.6%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 4183 has high quality earnings.

Growing Profit Margin: 4183's current net profit margins (4.8%) are higher than last year (4.1%).


Past Earnings Growth Analysis

Earnings Trend: 4183's earnings have grown by 10.6% per year over the past 5 years.

Accelerating Growth: 4183's earnings growth over the past year (14.8%) exceeds its 5-year average (10.6% per year).

Earnings vs Industry: 4183 earnings growth over the past year (14.8%) exceeded the Medical Equipment industry 9.9%.


Return on Equity

High ROE: 4183's Return on Equity (7.3%) is considered low.


Financial Health

How is EPS Bio Technology's financial position?


Financial Position Analysis

Short Term Liabilities: 4183's short term assets (NT$365.0M) exceed its short term liabilities (NT$124.3M).

Long Term Liabilities: 4183's short term assets (NT$365.0M) exceed its long term liabilities (NT$125.2M).


Debt to Equity History and Analysis

Debt Level: 4183's debt to equity ratio (7.4%) is considered satisfactory.

Reducing Debt: 4183's debt to equity ratio has reduced from 17.8% to 7.4% over the past 5 years.

Debt Coverage: 4183's debt is well covered by operating cash flow (208%).

Interest Coverage: 4183's interest payments on its debt are well covered by EBIT (18x coverage).


Balance Sheet


Dividend

What is EPS Bio Technology current dividend yield, its reliability and sustainability?

6.00%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 4183's dividend (6%) is higher than the bottom 25% of dividend payers in the TW market (1.99%).

High Dividend: 4183's dividend (6%) is in the top 25% of dividend payers in the TW market (5.04%)


Stability and Growth of Payments

Stable Dividend: 4183 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: 4183's dividend payments have increased, but the company has only paid a dividend for 9 years.


Current Payout to Shareholders

Dividend Coverage: With its high payout ratio (129.4%), 4183's dividend payments are not well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

EPS Bio Technology has no CEO, or we have no data on them.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

EPS Bio Technology Corp.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: EPS Bio Technology Corp.
  • Ticker: 4183
  • Exchange: TPEX
  • Founded: NaN
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: NT$476.000m
  • Shares outstanding: 23.80m
  • Website: https://epsbio.com

Number of Employees


Location

  • EPS Bio Technology Corp.
  • No. 8, R&D Road III
  • Hsinchu Science Park
  • Hsinchu City
  • Taiwan

Listings


Biography

EPS Bio Technology Corp. manufactures and sells OEM/ODM glucose meters and strips primarily in Taiwan. It provides blood glucose monitoring systems under the MDT2, EME, EMMU, EMV2, MasterDrive, 2IN1, and R...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/06/22 08:36
End of Day Share Price2021/06/21 00:00
Earnings2021/03/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.